2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 23816875 | Phase II study of topotecan and bevacizumab in advanced, refractory non--small-cell lung cancer. | 2013 Sep | 1 |
| 2 | 22158045 | SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15. | 2012 Sep 13 | 1 |